AHRQ plans effectiveness review of tests for breast abnormalities
This article was originally published in The Gray Sheet
Executive Summary
Agency for Healthcare Research and Quality posts for review three key questions on the comparative effectiveness of noninvasive diagnostic tests for breast abnormalities. The review will evaluate ultrasound, magnetic resonance imaging, positron emission tomography and scintimammography for the diagnosis of breast cancer in women referred for tests after a possible breast abnormality is found during routine screening. AHRQ will address key demographic risk factors and clinical risk factors, as well as other potential risk factors that could impact test accuracy. Comments on the draft questions are due May 5